Serum polysialylated neural cell adhesion molecule in childhood neuroblastoma.
暂无分享,去创建一个
D. V. von Schweinitz | R. Gerardy-Schahn | S. Glüer | N. Madry | M. Eckhardt | C. Schelp | Rita Gerardy-Schahn | D. V. Schweinitz | Matthias Eckhardt
[1] D. Figarella-Branger,et al. Correlation between polysialic-neural cell adhesion molecule levels in CSF and medulloblastoma outcomes. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[2] S. R. Smith,et al. Serum neural cell adhesion molecule in multiple myeloma and other plasma cell disorders , 1996, British journal of haematology.
[3] F. Lottspeich,et al. Molecular cloning and functional expression of bacteriophage PK1E‐encoded endoneuraminidase Endo NE , 1995, Molecular microbiology.
[4] G. Jaques,et al. Characterization of tumor-associated neural cell adhesion molecule in human serum. , 1994, Cancer research.
[5] G. Rougon. Structure, metabolism and cell biology of polysialic acids. , 1993, European journal of cell biology.
[6] U. Rutishauser,et al. Intercellular space is affected by the polysialic acid content of NCAM , 1992, The Journal of cell biology.
[7] P. Lacor,et al. Expression of cytoadhesion molecules (CD56, CD54, CD18 and CD29) by myeloma plasma cells , 1991, British journal of haematology.
[8] D. Bitter‐Suermann,et al. Embryonic Neural Cell Adhesion Molecule in Cerebrospinal Fluid of Younger Children: Age‐Dependent Decrease During the First Year , 1990, Journal of neurochemistry.
[9] C. Figdor,et al. Expression of neural cell adhesion molecule-related sialoglycoprotein in small cell lung cancer and neuroblastoma cell lines H69 and CHP-212. , 1990, Cancer research.
[10] F. Walsh,et al. Monoclonal antibody UJ13A recognizes the neural cell adhesion molecule (NCAM) , 1989, International journal of cancer.
[11] D. Bitter‐Suermann,et al. Interaction of meningococcal group B monoclonal antibody and its Fab fragment with alpha 2-8-linked sialic acid polymers: requirement of a long oligosaccharide segment for binding. , 1989, Molecular immunology.
[12] K. Timmis,et al. NZB mouse system for production of monoclonal antibodies to weak bacterial antigens: isolation of an IgG antibody to the polysaccharide capsules of Escherichia coli K1 and group B meningococci. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[13] H Stein,et al. Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes). , 1984, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[14] H. B. Marsden,et al. Histologic patterns of neuroblastoma related to prognosis and clinical staging , 1974, Cancer.
[15] G. Jaques,et al. Serum NCAM: a potential new prognostic marker for multiple myeloma. , 1994, Blood.
[16] G. Pelosi,et al. Detection of the neural cell adhesion molecule (NCAM) in serum of patients with small‐cell lung cancer (SCLC) with “limited” or “extensive” disease, and bone‐marrow infiltration , 1994, International journal of cancer. Supplement = Journal international du cancer. Supplement.
[17] T. Grogan,et al. Plasma cells in multiple myeloma express a natural killer cell-associated antigen: CD56 (NKH-1; Leu-19). , 1990, Blood.